Skip to main content

Month: September 2024

StorageVault Completes Purchase for $71,500,000

TORONTO, Sept. 18, 2024 (GLOBE NEWSWIRE) — STORAGEVAULT CANADA INC. (“StorageVault”) (SVI-TSX) is pleased to announce that it has completed the acquisition of the two adjacent properties, located in Toronto, ON announced on July 16, 2024 for an aggregate purchase price of $71,500,000 (the “Acquisition”). The total purchase price of the Acquisition, subject to customary adjustments, was paid with a mortgage and funds on hand. About StorageVault Canada Inc.StorageVault currently owns and operates 249 storage locations across Canada. StorageVault owns 219 of these locations plus over 5,000 portable storage units representing over 12.4 million rentable square feet on over 715 acres of land. StorageVault also provides last mile storage and logistics’ solutions and professional records management services, ‎such as document and media...

Continue reading

Organon to Acquire Dermavant including its Innovative Dermatologic Therapy, VTAMA® (tapinarof) Cream, 1%

VTAMA cream is a novel, non-steroidal topical therapy approved for treatment of plaque psoriasis in adults and is under FDA review for an additional indication to treat atopic dermatitis Proposed acquisition extends Organon’s international dermatology capabilities to the U.S. BASEL, Switzerland and LONDON and NEW YORK, Sept. 18, 2024 (GLOBE NEWSWIRE) — Organon (NYSE: OGN), a global healthcare company with a mission to improve the health of women throughout their lives, and Dermavant Sciences Ltd. announced today that they have entered into a definitive agreement, under which Organon will acquire Dermavant, a Roivant (NASDAQ: ROIV) company dedicated to developing and commercializing innovative therapeutics in immuno-dermatology. Dermavant’s novel product, VTAMA® (tapinarof) cream, 1%, for the topical treatment of mild, moderate,...

Continue reading

WillScot and McGrath RentCorp Mutually Agree to Terminate Previously Announced Combination

WillScot Remains Focused on Executing $1 Billion of Idiosyncratic Growth Opportunities Board Increases Share Repurchase Authorization to $1 Billion PHOENIX, Sept. 18, 2024 (GLOBE NEWSWIRE) — WillScot Holdings Corporation (“WillScot” or the “Company”) (Nasdaq: WSC), a leader in innovative temporary flexible space solutions, today announced that it has entered into an agreement with McGrath RentCorp (“McGrath”) (Nasdaq: MGRC) to terminate the companies’ previously announced merger, pursuant to the terms of the January 28, 2024 merger agreement, under which WillScot would have acquired McGrath for a mix of cash and stock consideration. Although both companies continue to believe in the merits and procompetitive benefits of the combination, WillScot and McGrath mutually agreed to terminate the transaction based on a joint determination...

Continue reading

Dental Consumables Market to Reach USD 53.27 Billion by 2031, Growing at 7.8% CAGR | SkyQuest Technology

With a CAGR of 9.2% over the forecast period, Asia Pacific is anticipated to have the fastest rate of regional market growth. Westford, USA, Sept. 18, 2024 (GLOBE NEWSWIRE) — SkyQuest projects that Dental Consumables Market will attain the value of USD 53.27 Billion by 2031, with a CAGR of 7.8% during the forecast period (2024-2031). Increased incidence of dental diseases, increased demand for cosmetic dentistry, growing dental tourism in global markets and higher disposable incomes in developing regions are some of the other drivers of the market. The global market is heavily influenced by high risk of cross-contamination & people’s fear of venturing outdoors. During the initial lockdown, the frequency of visits to hospitals and clinics for dental purposes, general dental appointments and oral examinations decreased...

Continue reading

Accolade to Announce Fiscal Second Quarter 2025 Financial Results

SEATTLE, Sept. 18, 2024 (GLOBE NEWSWIRE) — Accolade, Inc. (NASDAQ: ACCD) today announced that it will release fiscal second quarter 2025 financial results on Tuesday, October 8, 2024 before market open. In conjunction, the company will host a conference call to review results at 8:00 a.m. E.T. on the same day. Conference Call Details To Listen via Telephone: Pre-registration is required by the conference call operator. Please pre-register by clicking here (https://register.vevent.com/register/BI0b6b999c6e7b47fdb26d7e8a774df09f). Upon registering, you will be emailed a dial-in number, direct passcode and unique PIN. To Listen via Internet: The conference call can be accessed via a live audio webcast that will be available online at http://ir.accolade.com . Replay: A replay of the call will be available for one year via webcast for...

Continue reading

Huhtamaki’s financial reporting 2025

HUHTAMÄKI OYJ STOCK EXCHANGE RELEASE 18.9.2024 AT 14:00 In 2025, Huhtamaki will publish financial information as follows:Results 2024 February 14Annual report 2024 Week commencing March 10Interim report, January 1-March 31,2025 April 24Half-yearly report, January 1-June 30, 2025 July 24Interim report, January 1-September 30, 2025 October 23Huhtamaki observes a silent period prior to the publication of financial information. The silent period before publication of the 2024 Results is four weeks. The silent period before publication of the half-yearly report and interim reports starts on the last day of the reporting period in question. Huhtamäki Oyj’s Annual General Meeting (AGM) is planned to be held on Thursday, April 24, 2025. The Board of Directors will summon the AGM at a later date. A shareholder may request...

Continue reading

HONKARAKENNE OYJ – MANAGERS’ TRANSACTIONS

HONKARAKENNE OYJ Stock Exchange Release 18 September 2024 at 14:00 HONKARAKENNE OYJ – MANAGERS’ TRANSACTIONS Honkarakenne Oyj – Managers’ Transactions____________________________________________Person subject to the notification requirementName: Eino Hekali Position: Other senior manager Issuer: Honkarakenne OyjLEI: 7437007POZXRBIWNJ629Notification type: INITIAL NOTIFICATIONReference number: 77779/4/6____________________________________________Transaction date: 2024-08-23Venue: NASDAQ HELSINKI LTD (XHEL) Instrument type: SHAREISIN: FI0009900104Nature of transaction: ACQUISITION Transaction details(1): Volume: 204 Unit price: 2.9 EUR Aggregated transactions (1): Volume: 204 Volume weighted average price: 2.9 EUR ____________________________________________Transaction date: 2024-08-27Venue: NASDAQ HELSINKI LTD (XHEL)...

Continue reading

Oxford Biomedica rebrands as OXB reinforcing transformation into leading global cell and gene therapy CDMO

Oxford Biomedica rebrands as OXB reinforcing transformation into leading global cell and gene therapy CDMO Oxford, UK – 18 September 2024: OXB (LSE:OXB), a quality and innovation-led cell and gene therapy CDMO, today announces the launch of its new corporate brand. Oxford Biomedica is rebranding as OXB, unveiling a more modern and recognisable visual identity that reinforces its transformation into a global pure-play cell and gene therapy CDMO. The new identity reflects OXB’s unique combination of technical excellence, innovation and unwavering commitment to deliver consistent high quality at every stage of viral vector development and manufacturing. The new branding represents the agile execution and creativity that enable OXB to deliver on clients’ goals, while also conveying accountability, professionalism and teamwork – core values...

Continue reading

Construction contract (Apartment building in Ovruch, Ukraine)

Nordecon AS, together with its subsidiary Eurocon Ukraine TOV as joint bidders, and the Estonian Centre for International Development (ESTDEV) have signed a construction contract for the reconstruction of a building into an apartment complex for internally displaced persons in Ovruch, Zhytomyr Oblast, Ukraine. The contract value is 1.8 million euros, plus VAT, and the construction period is 275 days. Nordecon (www.nordecon.com) is a group of construction companies whose core business is construction project management and general contracting in the buildings and infrastructures segment. Geographically the Group operates in Estonia, Ukraine and Sweden. The parent of the Group is Nordecon AS, a company registered and located in Tallinn, Estonia. The consolidated revenue of the Group in 2023 was 278 million euros. Currently Nordecon Group...

Continue reading

Stallion Uranium Strategically Expands Largest Land Package in the Prolific Southwestern Athabasca Basin

VANCOUVER, British Columbia, Sept. 18, 2024 (GLOBE NEWSWIRE) — Stallion Uranium Corp. (the “Company” or “Stallion”) (TSX-V: STUD; OTCQB: STLNF; FSE: FE0) is pleased to announce that it has acquired by low-cost staking ten new prospective uranium exploration dispositions (or “claims”). The new claims will make up the Company’s Stone Island Project, covering 9,993 hectares and further bolstering Stallion’s land package in the prolific Southwestern Athabasca Basin. The new dispositions are contiguous to the Western Athabasca Basin JV Project (Stallion and Atha Energy) and are 100% owned by Stallion Uranium. Key Exploration HighlightsStaked 9,993 ha of contiguous claims New dispositions host the extension of Stallion’s Coyote Corridor Shallow depth to Unconformity of 100-400m Hosts the extensions of known...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.